IL92854A - Controlled release, low-dose aspirin formulation and its preparation - Google Patents

Controlled release, low-dose aspirin formulation and its preparation

Info

Publication number
IL92854A
IL92854A IL9285489A IL9285489A IL92854A IL 92854 A IL92854 A IL 92854A IL 9285489 A IL9285489 A IL 9285489A IL 9285489 A IL9285489 A IL 9285489A IL 92854 A IL92854 A IL 92854A
Authority
IL
Israel
Prior art keywords
parts
aspirin
granules
usp
release
Prior art date
Application number
IL9285489A
Other languages
English (en)
Other versions
IL92854A0 (en
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/293,832 external-priority patent/US4970081A/en
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of IL92854A0 publication Critical patent/IL92854A0/xx
Publication of IL92854A publication Critical patent/IL92854A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL9285489A 1989-01-03 1989-12-22 Controlled release, low-dose aspirin formulation and its preparation IL92854A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/293,832 US4970081A (en) 1989-01-03 1989-01-03 Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US42662089A 1989-10-24 1989-10-24

Publications (2)

Publication Number Publication Date
IL92854A0 IL92854A0 (en) 1990-09-17
IL92854A true IL92854A (en) 1994-11-28

Family

ID=26968181

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9285489A IL92854A (en) 1989-01-03 1989-12-22 Controlled release, low-dose aspirin formulation and its preparation

Country Status (20)

Country Link
EP (1) EP0377439B1 (de)
JP (1) JP2966871B2 (de)
KR (1) KR0151590B1 (de)
AR (1) AR244548A1 (de)
AT (1) ATE127690T1 (de)
AU (1) AU622254B2 (de)
CA (1) CA2006975C (de)
DE (1) DE69022251T2 (de)
DK (1) DK0377439T3 (de)
ES (1) ES2076975T3 (de)
FI (1) FI95776C (de)
GR (1) GR3017576T3 (de)
HK (1) HK35396A (de)
IE (1) IE69270B1 (de)
IL (1) IL92854A (de)
MX (1) MX174376B (de)
MY (1) MY104871A (de)
NO (1) NO177127C (de)
NZ (1) NZ231954A (de)
PT (1) PT92780B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
DE69826660T2 (de) * 1997-06-11 2005-10-06 The Procter & Gamble Company, Cincinnati Filmüberzogene tablette für verbesserte verträglichkeit im oberen magen-darmtrakt
US20060177502A1 (en) * 2005-01-06 2006-08-10 Srikonda Sastry Sustained release pharmaceutical formulations
WO2008140459A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
KR101109633B1 (ko) * 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
MX386908B (es) * 2015-10-09 2025-03-19 Bayer Healthcare Llc Formulacion de liberacion modificada de naproxeno sodico.
JP7219623B2 (ja) * 2018-01-30 2023-02-08 日東電工株式会社 経皮吸収型製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3264867D1 (en) * 1981-04-27 1985-08-29 Haessle Ab New pharmaceutical preparation
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
AU618589B2 (en) * 1988-04-05 1992-01-02 Kyowa Hakko Kogyo Co. Ltd. Oral compositions for ruminants
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin

Also Published As

Publication number Publication date
NO177127B (no) 1995-04-18
JPH02262520A (ja) 1990-10-25
DE69022251T2 (de) 1996-05-02
PT92780A (pt) 1990-07-31
DK0377439T3 (da) 1995-10-30
IE69270B1 (en) 1996-08-21
FI900017A0 (fi) 1990-01-03
NO900009L (no) 1990-07-04
KR900011453A (ko) 1990-08-01
IE894120L (en) 1990-07-03
IL92854A0 (en) 1990-09-17
MX18883A (es) 1993-09-01
CA2006975A1 (en) 1990-07-03
FI900017L (fi) 1990-07-04
DE69022251D1 (de) 1995-10-19
ATE127690T1 (de) 1995-09-15
CA2006975C (en) 2000-04-04
HK35396A (en) 1996-03-08
GR3017576T3 (en) 1995-12-31
NO900009D0 (no) 1990-01-02
AU4719489A (en) 1990-07-12
FI95776C (fi) 1996-03-25
MY104871A (en) 1994-06-30
AU622254B2 (en) 1992-04-02
EP0377439B1 (de) 1995-09-13
EP0377439A3 (de) 1991-02-06
AR244548A1 (es) 1993-11-30
FI95776B (fi) 1995-12-15
EP0377439A2 (de) 1990-07-11
PT92780B (pt) 1997-12-31
NO177127C (no) 1995-07-26
JP2966871B2 (ja) 1999-10-25
ES2076975T3 (es) 1995-11-16
NZ231954A (en) 1991-12-23
KR0151590B1 (ko) 1998-10-15
MX174376B (es) 1994-05-11

Similar Documents

Publication Publication Date Title
US4970081A (en) Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US4794001A (en) Formulations providing three distinct releases
US4728512A (en) Formulations providing three distinct releases
US4904476A (en) Formulations providing three distinct releases
EP1940361B1 (de) Pharmazeutische dosierformen mit sofortiger freisetzung und/oder kontrollierter freisetzung
AU750617B2 (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
US20010001658A1 (en) Granule modulating hydrogel system
EP2389167A2 (de) Feste pharmazeutische zusammensetzungen aus trimetazidin mit modifizierter freisetzung und verfahren dafür
WO2006128070A2 (en) Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a gabab receptor agonist
EP0377439B1 (de) Niedrigdosiertes Aspirin mit gesteuerter Freigabe
US20050220873A1 (en) Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist
AU732210B2 (en) Colonic delivery of weak acid drugs
US20090136550A1 (en) Modified release formulations of diltiazem
WO2005097079A2 (en) Controlled release dosage for gaba receptor agonist
US20050220863A1 (en) Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist
US20050220874A1 (en) Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist
HUT70759A (en) Stabile pharmaceutical compositions containing ipsapiron having retard effect
US20040228918A1 (en) Granule modulating hydrogel system
US20050220864A1 (en) Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist
KR20090128918A (ko) 염산 알푸조신이 함유된 서방형 제제의 제조
MXPA01002821A (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
MXPA99003093A (en) Colonic delivery of weak acid drugs

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired